scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JAGP.2013.01.030 |
10.1097/JGP.0B013E31826576CF | ||
P3181 | OpenCitations bibliographic resource ID | 3586210 |
P932 | PMC publication ID | 3543487 |
P698 | PubMed publication ID | 23567381 |
P50 | author | David Oslin | Q90363772 |
Michael E Thase | Q91359309 | ||
P2093 | author name string | Donovan T. Maust | |
P2860 | cites work | Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology | Q22241632 |
“Mini-mental state” | Q25938989 | ||
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report | Q28261272 | ||
Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. | Q33288908 | ||
Treatment-resistant depression in late life | Q33609576 | ||
Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission | Q33917532 | ||
Medication augmentation after the failure of SSRIs for depression. | Q33994373 | ||
National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 | ||
Antidepressant versus placebo for depressed elderly. | Q34281581 | ||
Depression in the elderly | Q34423873 | ||
What happened to lithium? Antidepressant augmentation in clinical settings | Q34543983 | ||
The significance of depression in older patients after myocardial infarction | Q34655466 | ||
Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials | Q34997918 | ||
The depression care manager and mental health specialist as collaborators within primary care | Q35541745 | ||
Achieving effective antidepressant pharmacotherapy in primary care: the role of depression care management in treating late-life depression | Q35903210 | ||
The efficacy of antidepressants in the treatment of late-life depression | Q36199600 | ||
The pharmacokinetic imperative in late-life depression | Q36199612 | ||
Aging and clinical pharmacology: implications for antidepressants | Q36261418 | ||
Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression | Q37459431 | ||
Antidepressant use, depression, and survival in patients with heart failure | Q37467525 | ||
Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial | Q38395087 | ||
Star-D: lessons learned and future implications | Q39733402 | ||
Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis | Q40929765 | ||
Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial | Q42617393 | ||
Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy | Q42622459 | ||
Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients | Q42624394 | ||
Citalopram and bupropion-SR: combining versus switching in patients with treatment-resistant depression | Q42625289 | ||
What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression | Q43251150 | ||
A novel augmentation strategy for treating resistant major depression | Q43514882 | ||
Rates and predictors of mortality in an aging, rural, community-based cohort: the role of depression | Q43680688 | ||
Methylphenidate augmentation of citalopram in elderly depressed patients | Q43692931 | ||
Discontinuation of lithium augmentation in an elderly cohort | Q43770878 | ||
Depression Predicts Increased Incidence of Adverse Health Outcomes in Older Mexican Americans With Type 2 Diabetes | Q44607862 | ||
Disability in geriatric depression. | Q44760843 | ||
Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors | Q45218021 | ||
Outcome of late-life depression after 3 years of sequential treatment | Q46215843 | ||
Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a double-blind, placebo-controlled pilot trial | Q46440521 | ||
Telephone-based behavioral health assessment for older adults starting a new psychiatric medication | Q48281678 | ||
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. | Q48878233 | ||
Major depression as a predictor of premature deaths in elderly people in Finland: a community study. | Q50875853 | ||
Maximizing efficiency and impact in effectiveness and services research. | Q51838149 | ||
An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression. | Q51906231 | ||
Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. | Q51951812 | ||
High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression. | Q52006807 | ||
A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. | Q52023209 | ||
The impact of depressive symptomatology on physical disability: MacArthur Studies of Successful Aging. | Q53655700 | ||
Lithium augmentation for treatment-resistant depression in the elderly. | Q54393241 | ||
Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system. | Q54415405 | ||
Lithium-antidepressant combinations in the treatment of depressed, physically ill geriatric patients. | Q54665585 | ||
What Happened to Lithium? Antidepressant Augmentation in Clinical Settings | Q56534248 | ||
Lithium augmentation in geriatric depression | Q60450493 | ||
The effect of sequential antidepressant treatment on geriatric depression | Q71567632 | ||
Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients | Q71590804 | ||
Gradual discontinuation of lithium augmentation in elderly patients with unipolar depression | Q72999534 | ||
Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties | Q74236082 | ||
Maintenance treatment of major depression in old age | Q82843539 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 973-86 | |
P577 | publication date | 2013-10-01 | |
P1433 | published in | American Journal of Geriatric Psychiatry | Q15752426 |
P1476 | title | Going beyond antidepressant monotherapy for incomplete response in nonpsychotic late-life depression: a critical review | |
P478 | volume | 21 |